Get started
Author

Juthamas Prawjaeng

Observed names: J. Prawjaeng, Prawjaeng, Juthamas
ORCID: 0000-0003-3356-7890
Observed ORCID: 0000-0003-3356-7890
OpenAlex ID: A5039824776
Cost-effectiveness analysis of HLA-B*58
2017 · Huey Yi Chong, Yi Heng Lim, et al. · Pharmacogenetics and Genomics · 42
Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic
2022 · Yi Wang, Nantasit Luangasanatip, et al. · The European Journal of Health Economics · 18
PDF
A cost-utility analysis of adding SGLT2 inhibitors for the management of type 2 diabetes with chronic kidney disease in Thailand
2025 · Natthakan Chitpim, Pattara Leelahavarong, et al. · Scientific Reports · 12
PDF
Cost-Utility and Budget Impact Analysis of Adding SGLT-2 Inhibitors to Standard Treatment in Type 2 Diabetes Patients with Heart Failure: Utilizing National Database Insights from Thailand
2024 · Tanawan Kongmalai, Juthamas Prawjaeng, et al. · PharmacoEconomics - Open · 8
PDF
Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
2023 · Juthamas Prawjaeng, Pattara Leelahavarong, et al. · BMC Health Services Research · 8
PDF
Onasemnogene Abeparvovec Gene Therapy and Risdiplam for the Treatment of Spinal Muscular Atrophy in Thailand: A Cost-Utility Analysis
2024 · Sarayuth Khuntha, Juthamas Prawjaeng, et al. · Applied Health Economics and Health Policy · 7
PDF
Optimal vaccine strategy to control COVID-19 pandemic in middle-income countries: Modelling case study of Thailand
2021 · Nantasit Luangasanatip, Wirichada Pan-Ngum, et al. · Research Square · 7
PDF
Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines
2021 · Chris Painter, Wanrudee Isaranuwatchai, et al. · Applied Health Economics and Health Policy · 5
PDF
Binding and neutralizing antibody levels and vaccine efficacy/effectiveness compared between heterologous and homologous primary series COVID-19 vaccination: A systematic review and meta-analysis
2022 · Nasikarn Angkasekwinai, Juthamas Prawjaeng, et al. · Asian Pacific Journal of Allergy and Immunology · 4
PDF
Advocating evidence-informed policy in Thailand: The case of the development of bicycle commuting policy framework
2022 · Theerapat Ungsuchaval, Kanang Kantamaturapoj, et al. · Case Studies on Transport Policy · 4
PDF
A Data-Driven Analysis of the Economic Cost of Non-Pharmaceutical Interventions: A Cross-Country Comparison of Kenya, Singapore, and Thailand
2022 · Jamaica Briones, Yi Wang, et al. · International Journal of Public Health · 4
PDF
Botulinum toxin type A for the treatment of patients with post-stroke spasticity in Thailand: cost-utility and budget impact analysis
2025 · Phorntida Hadnorntun, Juthamas Prawjaeng, et al. · BMJ Open · 3
PDF
Efficacy and safety of biologic, biosimilars and targeted synthetic DMARDs in moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: a systematic review and network meta-analysis
2023 · Nuttakarn Budtarad, Juthamas Prawjaeng, et al. · medRxiv · 2
PDF
Cost-utility analysis of cerebrospinal fluid versus blood biomarkers for early detection of Alzheimer’s disease and mild cognitive impairment in Thailand: a modeling study
2026 · Pattara Leelahavarong, Juthamas Prawjaeng, et al. · BMC Health Services Research · 1
Botulinum Toxin Type A for the Treatment of Focal Spasticity in Children With Cerebral Palsy in Thailand: A Cost-Utility and Budget Impact Analysis
2026 · Juthamas Prawjaeng, Phorntida Hadnorntun, et al. · Value in Health Regional Issues
Effect of Long-Term Exposure to Particulate Matter on the Risk of Lung Cancer in Non-Smokers: A Systematic Review and Meta-Analysis
2026 · NUTWARA KIJTHAMMARAT, Krittin Prechachaisurat, et al. · SSRN Electronic Journal
Effect of Long-Term Exposure to Particulate Matter on the Risk of Lung Cancer in Non-Smokers: A Systematic Review and Meta-Analysis
2026 · NUTWARA KIJTHAMMARAT, Sakditat Ittiphisit, et al. · SSRN Electronic Journal
EE466 Financial Impact of Dementia Care on Thai Households: A Multicenter Study of Informal Care Costs and Contributing Factors
2025 · Juthamas Prawjaeng, Pattara Leelahavarong, et al. · Value in Health
PCR119 Health-Related Quality of Life in Patients With Mild Cognitive Impairment and Dementia and Their Caregivers in Thailand: A Cross-Sectional Study
2025 · Khanit Pisawong, varalak srinonprasert, et al. · Value in Health
การประยกตใชระบบแพทยทางไกลในการดแลผปวยสงอายในสถานการณระบาดโรคโควด-19
2024 · Donsamak, Sisira, Leelahavarong, Pattara, et al. · Isan Journal of Pharmaceutical Sciences, IJPS (Isan J Pharm Sci)
PDF
EE424 Cost-Utility and Budget Impact Analyses of Tumor Necrosis Factor Inhibitor Biologics and Biosimilars Versus Rituximab in Thai Patients with Active Rheumatoid Arthritis
2023 · P. Leelahavarong, M. Osiri, et al. · Value in Health
PDF
EE310 Botulinum Toxin Type a for the Treatment of Patients with Post-Stroke Focal Spasticity in Thailand: A Cost-Utility Analysis
2023 · P. Hadnorntun, J. Prawjaeng, et al. · Value in Health
PDF
EE496 Botulinum Toxin Type a for the Treatment of Focal Spasticity in Children with Cerebral Palsy in Thailand: A Cost-Utility Analysis
2023 · J. Prawjaeng, P. Hadnorntun, et al. · Value in Health
PDF
Works count: 28
Citation count: 125
H-index: 7
I10-index: 3
Year
Topic
Type